Status:
ACTIVE_NOT_RECRUITING
Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Sarcoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial investigates whether measuring and presenting information about a patient's cancer treatment to them, their doctor, and their radiologist using a tool called an "oncology dashboard...
Detailed Description
PRIMARY OBJECTIVE: I. To compare the changes in oncology workflow times from baseline to follow up visits between intervention (follow-up visit with oncology dashboard tool) and control (follow-up vi...
Eligibility Criteria
Inclusion
- Patients with sarcoma on active chemotherapy/targeted therapy
- Patients must have stable to mildly progressive disease or better on baseline assessment
- Baseline measurement and follow-up measurement have to be performed on the same treatment for consistency. If patients with progressive disease are included into the study at baseline, follow-up measurement will be on a different treatment. Invariable, initiation of a new treatment, in the setting of progressive disease, lengthens oncology workflow which would affect the post measurement
- Patients must have been on the same treatment for at least 6 weeks
- Patients must have at least 3 prior imaging studies of the same body part/tracked lesion/area of interest separated by 6 weeks or more between studies
- Patients should be continuing same therapy for the next 6-8 weeks
- Patients must have plan for follow-up with imaging studies at MD Anderson Cancer Center (MDACC) while on therapy
- Patients who are receiving therapy outside of MDACC but having their follow-up imaging at MDACC are eligible
- \>= 18 years of age
Exclusion
- Expected survival of less than 8 weeks
- Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 4
- Non- English-speaking patients and patients with cognitive impairment who cannot complete the questionnaire
Key Trial Info
Start Date :
October 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2027
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT05216029
Start Date
October 1 2015
End Date
February 2 2027
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030